Speaking of suspect DD. That confetti, champagne and orange were a bit premature huh? Sad that we were a stage 3 bio two years ago and have yet to do shit when it comes to actual P3 clinical work. Most investors probably weren't familiar with the Phase 3 (IN NAME ONLY) bio company that Dixon and Ichim specialize in.
Market Data 
Markets 
AI
